Reply to “Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reply to “Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?”

Published:2023-02-24 Issue:9 Volume:129 Page:1455-1456
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Aleman Berthe M. P.¹^ORCID,Krul Inge M.²^ORCID,Janus Cécile P. M.³,van der Maazen Richard W. M.⁴,van Leeuwen Flora E.²

Affiliation:

1. Department of Radiation Oncology The Netherlands Cancer Institute Amsterdam The Netherlands

2. Department of Epidemiology The Netherlands Cancer Institute Amsterdam The Netherlands

3. Department of Radiation Oncology Erasmus University MC Cancer Institute Rotterdam The Netherlands

4. Department of Radiation Oncology Radboud University Medical Center Nijmegen The Netherlands

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34713

Reference9 articles.

1. Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma

2. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

3. Clinical Outcomes Confirm Conjecture: Modern Radiation Therapy Reduces the Risk of Late Toxicity in Survivors of Hodgkin Lymphoma

4. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

5. Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP